Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. (WSE:VOX) for PLN 11 million on September 21, 2012. Enterprise Investors already made an upfront payment of PLN 5 million, with the remainder payable at a later date, subject to certain conditions. Enterprise Investors will finance the development of the radiotherapy center in cooperation with a private company and a medical university.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
91.4 PLN | -2.35% | -4.19% | +16.28% |
05-27 | Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.28% | 243M | |
-22.07% | 7.87B | |
+75.81% | 4.52B | |
+6.76% | 2.78B | |
-2.80% | 2.62B | |
-50.25% | 2B | |
-18.67% | 1.68B | |
-19.73% | 1.47B | |
+18.95% | 1.22B | |
-44.86% | 1.12B |
- Stock Market
- Equities
- VOX Stock
- News Voxel S.A.
- Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million.